Showing results (351-360 of 372) with videos related to
Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1990
Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization studyV Mielke, J G Bauman, M Sticherling, et al.Nature Medicine|March 4, 2000
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybridsA Kugler, G Stuhler, P Walden, et al.Skin Pharmacology and Physiology|September 18, 2008
Optical coherent tomography for in vivo determination of changes in hair cross section and diameter during treatment with glucocorticosteroids--a simple method to screen for doping substances?J Lademann, J Shevtsova, A Patzelt, et al.The British Journal of Dermatology|February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonistsH-H Lee, I-H Song, M Friedrich, et al.International Journal of Cosmetic Science|September 11, 2012
In vivo methods for the analysis of the penetration of topically applied substances in and through the skin barrierJ Lademann, M C Meinke, S Schanzer, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.Archives of Internal Medicine|February 24, 1997
Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principleW J Kox, R C Bone, D Krausch, et al.Leukemia|June 1, 2011
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndromeF C M Braun, P Grabarczyk, M Möbs, et al.The British Journal of Dermatology|September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT studyR Dummer, A Guminksi, R Gutzmer, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 18, 2008
Human percutaneous absorption of a direct hair dye comparing in vitro and in vivo results: implications for safety assessment and animal testingJ Lademann, H Richter, U Jacobi, et al.Pageof 38